Q-linea AB (publ)
STO: QLINEA.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Anders Ljunggren
- Employees
- 97
- Headquarters
- Uppsala, Sweden
- IPO year
- 2018
- Market cap
- SEK 105.9M
- Website
- https://www.qlinea.com
Loading QLINEA…
Loading profile data…Frequently asked questions about QLINEA
What does Q-linea AB (publ) (QLINEA.ST) do?
Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in Sweden. It offers inventive systems for in vitro diagnostics systems for infectious diseases. The company's lead product candidate is ASTar, an antibiotic susceptibility testing system used for positive blood cultures. It develops and deliver...
Where does QLINEA.ST trade?
Q-linea AB (publ) (QLINEA.ST) trades on the Stockholm Stock Exchange.
What sector is QLINEA.ST in?
Q-linea AB (publ) (QLINEA.ST) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Q-linea AB (publ)?
Anders Ljunggren is the chief executive officer of Q-linea AB (publ) (QLINEA.ST).
Where is Q-linea AB (publ) headquartered?
Q-linea AB (publ) is headquartered in Sweden.
Does QLINEA.ST pay a dividend?
Q-linea AB (publ) (QLINEA.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did QLINEA.ST go public?
Q-linea AB (publ) (QLINEA.ST) completed its initial public offering in 2018.